Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
40 studies found for:    Open Studies | Exclude Unknown | liver | NIDDK
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | Exclude Unknown | liver | NIDDK
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Nonalcoholic Fatty Liver Disease (NAFLD) Adult Database 2
Condition: Liver Disease
Intervention:
2 Recruiting Longitudinal Study of Mitochondrial Hepatopathies
Conditions: Acute Liver Failure,;   Mitochondrial Diseases;   End Stage Liver Disease,;   Respiratory Chain Deficiencies, Mitochondrial;   Disorder of Fatty Acid Oxidation
Intervention:
3 Recruiting Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC)
Conditions: Liver Diseases;   Alagille Syndrome;   Alpha 1-Antitrypsin Deficiency
Intervention:
4 Recruiting NAFLD Pediatric Database 2
Condition: Liver Disease
Intervention:
5 Recruiting Adult-to-Adult Living Donor Transplant Cohort Study
Conditions: Liver Diseases;   Hepatocellular Cancer;   End Stage Liver Disease;   Hepatitis C;   Liver Cirrhosis
Intervention:
6 Recruiting Evaluation of Patients With Liver Disease
Conditions: Biliary Liver Cirrhosis,;   Hemochromatosis;   Hepatitis;   Hepatolenticular Degeneration;   Liver Disease
Intervention:
7 Recruiting Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E
Condition: Fatty Liver
Interventions: Dietary Supplement: Vitamin E 200 IU/d;   Dietary Supplement: Vitamin E 400 IU/d;   Dietary Supplement: Vitamin E 800 IU/d;   Behavioral: Diet and Exercise
8 Recruiting The Physiology of Fatigue in Patients With Chronic Liver Disease
Condition: Liver Disease
Intervention:
9 Recruiting A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
Conditions: Liver Diseases;   Hepatocellular Cancer;   Endstage Liver Disease;   Liver Cirrhosis
Intervention: Behavioral: donor pain management/ Pre-operative OR Set-up
10 Recruiting A Multi-Center Trial to Study Acute Liver Failure in Adults
Conditions: Acute Liver Failure;   Fulminant Hepatic Failure;   Acute Liver Injury
Intervention:
11 Recruiting Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure Due to Acetaminophen
Conditions: Acute Liver Failure;   Acute Liver Injury
Intervention: Drug: Ornithine phenylacetate
12 Recruiting A Multi-Center Group to Study Acute Liver Failure in Children
Conditions: Acute Liver Failure;   Hepatic Encephalopathy
Intervention:
13 Recruiting Drug-Induced Liver Injury (DILN)Network Retrospective
Condition: Drug Induced Liver Injury
Intervention:
14 Recruiting Observational Study of Biomarker During Liver Surgery
Conditions: Liver Cancer;   Hepatobiliary Tract Adenomas and Carcinomas
Intervention: Procedure: Hepatocellular carcinoma
15 Recruiting Evaluation of Sickle Cell Liver Disease
Condition: Sickle Cell Disease
Intervention:
16 Recruiting Carbamazepine in Severe Liver Disease Due to Alpha-1 Antitrypsin Deficiency
Conditions: Alpha-1-antitrypsin Deficiency;   Liver Cirrhosis
Interventions: Drug: Drug-Carbamazepine (Tegretol XR);   Drug: Carbamazepine (Tegretol XR) Placebo
17 Recruiting Genetic Modifiers of Cystic Fibrosis (CF) Liver Disease
Conditions: Cystic Fibrosis;   Liver Disease
Intervention:
18 Recruiting Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy
Conditions: Fatty Liver Disease, Nonalcoholic;   Nonalcoholic Steatohepatitis;   Lipodystrophy
Intervention: Drug: Metreleptin
19 Recruiting DILIN's Prospective Study
Condition: Liver Diseases
Intervention:
20 Recruiting New Treatment Response in People With and Without Cirrhosis From Chronic Hepatitis C
Conditions: Cirrhosis;   Chronic Hepatitis C;   Hepatitis C;   Hepatitis C, Chronic
Interventions: Drug: Asunaprevir and Daclatsvir;   Drug: Asunaprevir, daclatsvir, peginterferon, ribavirin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years